Tag: Oncodesign
Oncodesign: delivery of OPM shares on Friday, October 7
By Alexandra Saintpierre Published on 03/10/2022 at 07:49 (Boursier.com) — The…
Oncodesign’s General Meeting authorizes the allocation of Oncodesign Precision Medicine (OPM) shares to Oncodesign shareholders – 09/30/2022 at 6:00 p.m.
Dijon (France), September 30, 2022 at 6:00 p.m. – The Oncodesign General Meeting held on September 30, 2022 authorized the distribution of OPM shares to Oncodesign shareholders. Each Oncodesign shareholder…
Euronext Paris authorizes the listing of Oncodesign Precision Medicine (OPM) shares on Euronext Access+ as part of the allocation of OPM shares to Oncodesign shareholders – 09/28/2022 at 6:00 p.m.
– IPO planned at a reference price of €0.817/share – Fundraising in the amount of €8 million, guaranteed by OPM management, planned before the end of 2022 – Availability of…
Oncodesign: Servier exercises an option in Parkinson – 09/27/2022 at 12:21
(CercleFinance.com) – Oncodesign announced on Tuesday that Servier had exercised its exclusive worldwide license option on their joint program in the treatment of Parkinson’s disease. The lifting of this option…
Oncodesign: Servier lifts the exclusive worldwide license option on the program in collaboration with OPM
By Alexandra Saintpierre Published on 09/26/2022 at 7:14 p.m. Photo credit © Reuters …
Oncodesign: no reaction to announcements
By Hector Chaunu Published on 09/23/2022 at 09:24 Photo credit © Reuters (Boursier.com)…
Oncodesign: no impact
By Claude Leguilloux Published on 09/16/2022 at 4:54 p.m. Photo credit © Reuters …
Oncodesign: an attractive operation
Subscribe for 1€ Unlimited access to all advice More than 800 stocks listed in Paris and abroad screened. To buy ? Sale ? What course objective? Our experts engage and…
Oncodesign soars 52% for its resumption of listing
In order to externalize the value of its services division, which represents 90% of its income, the company has decided to spin it off. Suspended from trading since Thursday, the…
Oncodesign provides information relating to the General Meeting of Shareholders of June 30, 2022 – 06/13/2022 at 6:00 p.m.
Dijon, June 13, 2022 at 6:00 p.m. CEST – ONCODESIGN (FR0011766229 – ALONC), a biopharmaceutical group specializing in precision medicine, announces the availability of the preparatory documents for the Combined…
Oncodesign: an analyst adjusts after the announcements
By Hector Chaunu Published on 08/04/2022 at 11:26 (Boursier.com) — Oncodesign…
Oncodesign: With record revenues in 2021, Oncodesign wants to make its assets more readable
(BFM Bourse) – The outsourced research activity (CRO) boosted the Burgundian firm’s turnover to more than 30 million euros, while its order book grew even faster than invoicing. In 2022,…